Investing.com - Financial Markets Worldwide
Open in App

From Bio Co Ltd (377220)

KOSDAQ
Currency in KRW
2,960
+45(+1.54%)
Closed·

377220 Income Statement

Period Ending:
2021
31/12
2022
31/12
2023
31/12
2024
31/12
2025
31/12
Total Revenues
135,103.2799,330.466,723.9767,181.8872,162.17
Total Revenues Growth
--26.48%-32.83%+0.69%+7.41%
Cost Of Revenues
32,999.3330,021.5420,768.9530,036.4230,611.67
Gross Profit
102,103.9469,308.8645,955.0237,145.4541,550.5
Gross Profit Growth
--32.12%-33.7%-19.17%+11.86%
Gross Profit Margin %
75.57%69.78%68.87%55.29%57.58%
Other Operating Expenses, Total
90,680.2468,411.8461,375.4561,416.3260,151.74
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
--24.56%-10.29%+0.07%-2.06%
-----
90,018.0167,683.9760,432.1460,199.7958,943.39
-----
Operating Income
11,423.71897.02-15,420.43-24,270.87-18,601.23
Operating Income Growth
--92.15%-1,819.08%-57.39%+23.36%
EBIT Margin %
8.46%0.9%-23.11%-36.13%-25.78%
Net Interest Expenses
199.01719.12147.43-831.32-1,392.06
Net Interest Expenses Growth
-+261.35%-79.5%-663.9%-67.45%
Interest Expense, Total
-24.7-13.78-188.65-1,015.47-1,468.95
Interest And Investment Income
223.72732.91336.08184.1476.9
Other Non Operating Expenses, Total
30.27-100.9-602.24-68.11-1,270.69
EBT, Excl. Unusual Items
11,652.991,515.24-15,875.25-25,170.3-21,263.98
Gain (Loss) On Sale Of Assets
-12.09-2.89.84364389.84
Other Unusual Items, Total
-----
EBT, Incl. Unusual Items
11,638.061,512.38-15,740.38-24,892.28-20,878.18
EBT, Incl. Unusual Items Growth
--87%-1,140.77%-58.14%+16.13%
EBT, Incl. Unusual Items Margin
8.61%1.52%-23.59%-37.05%-28.93%
Income Tax Expense
355.96194.37-4,131.171,338.122,324.94
Net Income to Company
11,282.11,318.01-11,609.21-26,230.4-23,203.12
Minority Interest
-1,922.51533942.32745.96
Net Income
11,282.13,240.52-11,076.21-25,288.09-22,457.15
Net Income Growth
--71.28%-441.8%-128.31%+11.19%
Net Income Margin %
8.35%3.26%-16.6%-37.64%-31.12%
Preferred Dividend and Other Adjustments
-----
Net Income to Common Excl. Extra Items
11,282.13,240.52-11,076.21-25,288.09-22,457.15
Basic EPS - Continuing Operations
2,303.11572.33-1,956.24-4,465-3,966.29
Basic EPS - Continuing Operations Growth
--75.15%-441.8%-128.24%+11.17%
Diluted EPS - Continuing Operations
2,303.11570-1,956.24-4,465-3,966.29
Diluted EPS - Continuing Operations Growth
--75.25%-443.2%-128.24%+11.17%
Basic Weighted Average Shares Outstanding
4.95.665.665.665.66
Diluted Weighted Average Shares Outstanding
4.95.665.665.665.66
Dividend Per Share
-----
Dividend Per Share Growth
-----
EBITDA
12,496.062,039.3-13,775.43-21,976.08-16,601.66
EBITDA Growth
--83.68%-775.5%-59.53%+24.46%
EBITDA Margin %
9.25%2.05%-20.65%-32.71%-23.01%
EBIT
11,423.71897.02-15,420.43-24,270.87-18,601.23
* In Millions of KRW (except for per share items)

FAQ

What was From Bio’s revenue at year end?

At the end of the last reported fiscal year, From Bio (377220) recorded total revenue of 72,162 million KRW.

How much revenue did From Bio report in the most recent quarter?

In its most recent quarterly earnings report, From Bio posted revenue of 14,665 million KRW.

What was From Bio’s net income for the year?

For the full year, From Bio reported net income of -22,457 million KRW.

How much net income did From Bio post in the last quarter?

In the most recent quarter, From Bio (377220) posted net income of -1,168 million KRW.

What was From Bio’s gross profit for the year?

Gross profit for the year was reported at 41,551 million KRW.

How much gross profit did From Bio generate last quarter?

From Bio recorded gross profit of 11,776 million KRW in its latest quarterly report.

What was From Bio’s annual operating income?

For the full year, From Bio (377220) reported operating income of -18,601 million KRW.

What was From Bio’s operating income last quarter?

Quarterly operating income was -553 million KRW.

What was From Bio’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -91 million KRW.

What was the quarter-over-quarter change in EBITDA for From Bio?

EBITDA changed by 97% million KRW compared to the last quarter.

What is From Bio’s most recent gross profit margin?

The latest reported gross profit margin for From Bio (377220) is 80% million KRW.

What is From Bio’s most recent net income margin?

Net income margin based on recent financials is -8% million KRW.

What is From Bio’s most recent EBIT margin?

From Bio reported an EBIT margin of -4% million KRW based on current figures.

How did From Bio’s revenue change compared to the previous quarter?

Revenue changed by -24% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for From Bio?

In the latest quarter, gross profit changed by -4% million KRW from the previous quarter.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.